Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TGF-β: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | TGF-β |
| Key Genes/Proteins | AKT, MMP9, PDIA3, SMAD7 |
| Related Diseases | GBM, glioblastoma multiforme, Renal Fibrosis |
| Related Pathways | microglial TREM2 activation, Wnt |
Knowledge base pages for this entity
graph TD
TGF__[TGF-β]
TGF__ -->|causes| Renal_Fibrosis[Renal Fibrosis]
TGF__ -->|modulates| Inflammation[Inflammation]
TGF__ -->|regulates| glioblastoma_multiforme[glioblastoma multiforme]
TGF__ -->|activates| MMP9[MMP9]
TGF__ -.biomarker for.-> M2_anti_inflammatory_phenotype[M2 anti-inflammatory phenotype]
Britannin[Britannin] -->|downregulates| TGF__
Wnt[Wnt] -->|interacts| TGF__
SMAD7[SMAD7] -->|inhibits| TGF__
PDIA3[PDIA3] -->|interacts| TGF__
AKT[AKT] -->|regulates| TGF__| Target | Relation | Type | Str |
|---|---|---|---|
| MICROGLIA | activates | cell_type | 0.90 |
| MMT | associated_with | process | 0.80 |
| Renal Fibrosis | causes | disease | 0.80 |
| Wound healing | associated_with | process | 0.80 |
| Exosomes | associated_with | entity | 0.80 |
| Neuroinflammation | suppresses | process | 0.80 |
| Inflammation | modulates | process | 0.80 |
| microglial TREM2 activation | modulates | mechanism | 0.70 |
| GBM | associated_with | disease | 0.70 |
| glioblastoma multiforme | regulates | disease | 0.70 |
| MMP9 | activates | protein | 0.70 |
| M2 anti-inflammatory phenotype | biomarker_for | cell_type | 0.70 |
| Immune Response | interacts_with | pathway | 0.55 |
| Innate Immunity | interacts_with | pathway | 0.55 |
| Mtor | interacts_with | pathway | 0.55 |
| Nf-Κb | interacts_with | pathway | 0.55 |
| Mapk | interacts_with | pathway | 0.55 |
| Ferroptosis | interacts_with | pathway | 0.55 |
| Insulin Signaling | interacts_with | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Circadian Rhythm | interacts_with | pathway | 0.55 |
| ERBB3 | associated_with | concept | 0.50 |
| Epithelial-Mesenchymal Transition | associated_with | process | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| Pi3K/Akt | causes | pathway | 0.50 |
| Invasion | causes | pathway | 0.50 |
| disease | associated_with | disease | 0.50 |
| Pi3K/Akt | associated_with | pathway | 0.50 |
| PI3K/AKT/mTOR | associated_with | pathway | 0.50 |
| NOTCH | activates | pathway | 0.50 |
| Heart Failure | associated_with | disease | 0.50 |
| Cachexia | associated_with | disease | 0.50 |
| PI3K/AKT/mTOR | causes | pathway | 0.50 |
| BAMBI | regulates | concept | 0.50 |
| CYTOKINES | associated_with | concept | 0.50 |
| ENDOTHELIAL | associated_with | concept | 0.50 |
| Reactive Oxygen Species | associated_with | process | 0.50 |
| Liver Cancer | expressed_in | disease | 0.50 |
| Liver Cancer | inhibits | disease | 0.50 |
| Neuron | regulates | cell_type | 0.50 |
| NEURONS | regulates | concept | 0.50 |
| HIPPO | regulates | concept | 0.50 |
| TGFB | activates | gene | 0.50 |
| Fibroblast | activates | cell_type | 0.50 |
| Tgf-Β Signaling | activates | pathway | 0.50 |
| CYTOKINES | activates | concept | 0.50 |
| TNF-α | activates | concept | 0.50 |
| IGF-1 | regulates | concept | 0.50 |
| RAPAMYCIN | regulates | concept | 0.50 |
| Macrophage | activates | cell_type | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Inflammation | regulates | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| CANCER | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| AKT | associated_with | gene | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| PI3K | associated_with | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| TNF | activates | gene | 1.00 |
| MTOR | activates | gene | 1.00 |
| Fibrosis | regulates | disease | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| PI3K | inhibits | gene | 1.00 |
| AKT | inhibits | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| IL-6 | activates | gene | 1.00 |
| Neuroinflammation | activates | disease | 0.90 |
| NEUROINFLAMMATION | activates | gene | 0.90 |
| ROS | inhibits | gene | 0.90 |
| Fibrosis | therapeutic_target | disease | 0.90 |
| OXIDATIVE STRESS | inhibits | gene | 0.90 |
| Als | associated_with | disease | 0.90 |
| Fibrosis | activates | disease | 0.90 |
| MIRNAS | regulates | gene | 0.90 |
| APOPTOSIS | activates | gene | 0.90 |
| Carcinoma | activates | disease | 0.90 |
| CANCER | therapeutic_target | gene | 0.90 |
| Neurodegeneration | therapeutic_target | disease | 0.90 |
| CYTOKINES | inhibits | gene | 0.90 |
| Tumor | therapeutic_target | disease | 0.90 |
| Autoimmune | therapeutic_target | disease | 0.90 |
| Fibrosis | inhibits | disease | 0.90 |
| Britannin | downregulates | compound | 0.85 |
| Wnt | interacts_with | pathway | 0.80 |
| TNF | inhibits | gene | 0.80 |
| SMAD3 | activates | gene | 0.80 |
| STAT3 | regulates | gene | 0.80 |
| Cancer | inhibits | disease | 0.80 |
| STAT3 | activates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TGF-β1–SMAD2/3 Axis as Master Suppressor of Microglial Train | 0.712 | neuroinflammation | What specific astrocyte-derived factors |
| TGF-β1-SMAD Signaling Dysregulation | 0.380 | neurodegeneration | Which specific factors in conditioned me |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.64 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.92 · 2026-04-26
Hypotheses and analyses mentioning TGF-β in their description or question text
No additional research found